Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD.

Abstract

Tiotropium bromide is a long acting muscarinic antagonist (LAMA), marketed under the brand name Spiriva, for the treatment of chronic obstructive pulmonary disease (COPD). Besides its proven direct bronchodilatory activity, recent clinical studies demonstrated that tiotropium is able to reduce the exacerbation rate and impact the clinical course of COPD… (More)
DOI: 10.1016/j.pupt.2010.03.008

Topics

  • Presentations referencing similar topics